Advertisement
MO BIO
MO BIO

Features

» drug development and cancer

Most Recent

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

image: Child-Proofing Drugs

Child-Proofing Drugs

By | March 1, 2012

When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.

6 Comments

image: Vitamin D on Trial

Vitamin D on Trial

By | March 1, 2012

Prevention trials for vitamins and supplements are notoriously difficult, but some researchers aren’t giving up on finding proof that vitamin D helps ward off disease.

52 Comments

image: The War Within

The War Within

By | February 1, 2012

Unraveling the molecular causes of acute pancreatitis—a potentially deadly disease in which the pancreas essentially digests itself—is yielding clues to how it might be treated.

12 Comments

image: A Small Revolution

A Small Revolution

By | October 1, 2011

In fewer than 15 years, nanomedicine has gone from fantasy to reality.

0 Comments

image: Nanomedicine

Nanomedicine

October 1, 2011

At the nanoscale old materials acquire new properties that International Institute for Nanotechnology Director Chad Mirkin thinks will change the way medicine is practiced.

0 Comments

It's a Cell-Eat-Cell World

By | August 1, 2011

For more than 100 years, pathologists have observed cancer cells engulfing other live cells, but scientists are only now beginning to understand how it happens and what it means for tumorigenesis.

21 Comments

Vaccines

By | June 1, 2011

Looking back, looking ahead

18 Comments

image: Taking Aim at Melanoma

Taking Aim at Melanoma

By | April 1, 2011

Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.

0 Comments

image: An Aspirin for your Cancer?

An Aspirin for your Cancer?

By | April 1, 2011

Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies